论文部分内容阅读
为探讨血清ECP在哮喘诊断中的意义,我院于1996年2月~1998年4月对449例喘息性支气管炎、支气管哮喘发作期及缓解期患儿进行血清ECP测定。结果表明225例升高,占50.11%,其中喘支组升高为52.9%,均值为17.48+26.42μg/L,哮喘发作组升高为57.7%,均值为32.14±21.17μg/L,均较对照组,哮喘缓解组为高。提示两者发病本质与发病机理相同,仅是程度不同而已,且ECP水平反映了患儿气道炎症的活动情况,可根据ECP变化来监测哮喘疗效和判断病情。
In order to explore the significance of serum ECP in the diagnosis of asthma, our hospital from February 1996 to April 1998 449 cases of asthmatic bronchitis, bronchial asthma attack and remission in children with serum ECP determination. The results showed that 225 cases were elevated, accounting for 50.11%. The asthma exacerbation group increased to 52.9% with an average of 17.48 + 26.42μg / L and asthma exacerbation group increased to 57.7% with an average of 32.14 ± 21.17μg / L In the control group, asthma relief group was high. Suggesting that both pathogenesis and pathogenesis of the same nature, only to a different extent, and ECP level reflects the activity of children with airway inflammation, ECP changes can be based on the monitoring of asthma efficacy and to determine the condition.